INTERNATIONAL PATENT: IMMUNOCORE LIMITED FILES APPLICATION FOR "CD1A-PD-1 BISPECIFIC AGONIST FOR THE TREATMENT OF ATOPIC DERMATITIS"

GENEVA, July 14 -- IMMUNOCORE LIMITED (92 PARK DRIVEMILTON PARKABINGDON, OXON OX14 4RY) filed a patent application (PCT/IB2025/050090) for "CD1A-PD-1 BISPECIFIC AGONIST FOR THE TREATMENT OF ATOPIC DERMATITIS" on Jan 03, 2025. With publication no. WO/2025/146662, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CURNOCK, Adam (c/o Immunocore Limited92 Park Drive, Milton ParkAbingdon, Oxon OX14 4RY), OVERTON, David (c/o Immunocore Limited92 Park Drive, Milton ParkAbingdon, Oxon OX14 4RY)

Abstract: The present disclosure pr...